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The ability of Mycobacterium tuberculosis (Mtb) to persist in its human host relies on 
numerous immune evasion strategies, such as the deregulation of the lipid metabolism 
leading to the formation of foamy macrophages (FM). Yet, the specific host factors lead-
ing to the foamy phenotype of Mtb-infected macrophages remain unknown. Herein, we 
aimed to address whether host cytokines contribute to FM formation in the context of 
Mtb infection. Our approach is based on the use of an acellular fraction of tuberculous 
pleural effusions (TB-PE) as a physiological source of local factors released during Mtb 
infection. We found that TB-PE induced FM differentiation as observed by the increase 
in lipid bodies, intracellular cholesterol, and expression of the scavenger receptor CD36, 
as well as the enzyme acyl CoA:cholesterol acyl transferase (ACAT). Importantly, interleu-
kin-10 (IL-10) depletion from TB-PE prevented the augmentation of all these parameters. 
Moreover, we observed a positive correlation between the levels of IL-10 and the number 
of lipid-laden CD14+ cells among the pleural cells in TB patients, demonstrating that FM 
differentiation occurs within the pleural environment. Downstream of IL-10 signaling, we 
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noticed that the transcription factor signal transducer and activator of transcription 3 
was activated by TB-PE, and its chemical inhibition prevented the accumulation of lipid 
bodies and ACAT expression in macrophages. In terms of the host immune response, 
TB-PE-treated macrophages displayed immunosuppressive properties and bore higher 
bacillary loads. Finally, we confirmed our results using bone marrow-derived macrophage 
from IL-10−/− mice demonstrating that IL-10 deficiency partially prevented foamy phe-
notype induction after Mtb lipids exposure. In conclusion, our results evidence a role of 
IL-10 in promoting the differentiation of FM in the context of Mtb infection, contributing to 
our understanding of how alterations of the host metabolic factors may favor pathogen 
persistence.
Keywords: acaT, interleukin-10, foamy macrophages, lipids, signal transducer and activator of transcription 3, 
tuberculosis
inTrODUcTiOn
Tuberculosis (TB) is a highly contagious disease caused by 
Mycobacterium tuberculosis (Mtb) infection. Even though the 
treatment of the disease has been standardized for a while, 
TB still remains one of the top 10 causes of death worldwide 
with 10.4 million new cases and 1.3 million deaths from 
TB among HIV-negative people in 2016 (1). Chronic host– 
pathogen interaction in TB leads to extensive metabolic remod-
eling in both the host and the pathogen (2). In fact, the success 
of Mtb as a pathogen derives from its efficient adaptation to 
the intracellular milieu of human macrophages. An important 
strategy to reach this metabolic adaptation is the promotion 
of lipid body accumulation by the host macrophage leading 
to foamy macrophages (FM) differentiation. The formation of 
lipid-laden macrophages is caused by infectious agents through 
deregulation in the balance between the influx and efflux of 
lipids. Key for the biogenesis of lipid bodies is the enzyme acyl 
CoA:cholesterol acyltransferase (ACAT), which represents an 
ideal target for pathogens (3).
Lipid body accumulation within leukocytes is a common 
feature in both clinical and experimental infections, especially 
in mycobacterial infections (4, 5). Mtb infection leads to the 
induction of FM, a process which is promoted by several myco-
bacterial lipids (6–8). This event enables the fusion between 
Mtb-containing phagosomes and lipid bodies resulting in an 
abundant supply of lipids for the pathogen (7), allowing Mtb to 
switch into a dormancy phenotype and to become tolerant to 
several front-line antibiotics (9). For this reason, lipid bodies are 
considered to be a secure niche for Mtb conferring protection 
from bactericidal mechanisms, such as respiratory burst (10). 
Moreover, the presence of FM within granulomatous structures 
was demonstrated in both experimentally infected animals and 
patients, especially in individuals developing secondary TB 
(5, 11). Therefore, FM may play a central role in mycobacterial 
persistence and reactivation (12, 13).
Concerning the impact of FM on the host immunity against 
Mtb, it was shown that human macrophages exposed to lipids 
prior to Mtb infection failed to produce TNF-α and to clear 
the infection (14, 15). Taking into account that FM generated 
prior to Mtb infection impair the host immune response, 
there is a keen interest to identify the host-derived cytokines 
released at the site of Mtb infection, and to understand how 
these signals contribute to FM differentiation and alter host 
defense against Mtb. In this regard, it is well known that 
different activation programs in macrophages driven by pro 
or anti-inflammatory cytokines are associated to changes 
in the lipid metabolism (16). Therefore, it is likely that host 
cytokines produced in response to Mtb infection contribute 
to lipids turnover promoting FM formation, and consequently 
lead to Mtb persistence.
In this work, we report that a TB-associated microenviron-
ment induces FM differentiation program dependent partially 
on the interleukin-10 (IL-10)/signal transducer and activator 
of transcription 3 (STAT3) axis through ACAT upregulation. 
Our approach was to model a genuine TB-associated micro-
environment by employing a physiological relevant sample 
derived from active TB patients, such as the acellular fraction 
of tuberculous pleural effusions (TB-PE). Indeed, TB-PE are 
manifested in up to 30% of patients with TB, and they are caused 
by the spread of Mtb into the pleural space and subsequent local 
inflammation and recruitment of leukocytes (17). Based on 
this, we show that the acquisition of the foamy phenotype with 
immunosuppressive properties involves high IL-10 release, low 
TNF-α production, impaired Th1 activation, and high bacil-
lary loads. We also confirmed that IL-10-deficiency in bone 
marrow-derived macrophages (BMDM) prevented partially 
foamy phenotype induction upon exposure to Mtb lipids. 
In conclusion, our results provide evidence for a role of IL-10 
in promoting foamy differentiation of macrophages in the con-
text of Mtb infection.
MaTerials anD MeThODs
Bacterial strain and antigens
Mycobacterium tuberculosis H37Rv strain was grown at 37°C 
in Middlebrook 7H9 medium (Difco) supplemented with 10% 
albumin-dextrose-catalase (Difco) and 0.05% Tween-80 (Sigma-
Aldrich). The Mtb γ-irradiated H37Rv strain (NR-49098) and 
its total lipids’ preparation (NR-14837) were obtained from BEI 
Resource, USA.
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Preparation of human Monocyte-Derived 
Macrophages (MDM)
Buffy coats from healthy donors were prepared at Centro Regional 
de Hemoterapia Garrahan (Buenos Aires, Argentina) according 
to institutional guidelines (resolution number CEIANM-664/07). 
Informed consent was obtained from each donor before blood 
collection. Peripheral blood mononuclear cells were obtained 
by Ficoll gradient separation on Ficoll-Paque (GE Healthcare). 
Then, monocytes were purified by centrifugation on a discontinu-
ous Percoll gradient (Amersham) as previously described (18). 
After that, monocytes were allowed to adhere to 24-well plates 
(Costar) at 5 × 105 cells/well for 1 h at 37°C in warm RPMI-1640 
medium (GIBCO). The cells were then washed with warm PBS 
twice. The final purity was checked by fluorescence-activated 
cell sorting analysis using an anti-CD14 monoclonal antibody 
(mAb) and was found to be >90%. The medium was then sup-
plemented to a final concentration of 10% fetal bovine serum 
(FBS, Sigma-Aldrich) and human recombinant Macrophage 
Colony-Stimulating Factor (M-CSF, Peprotech) at 10  ng/ml. 
Cells were allowed to differentiate for 5–7 days.
Preparation of Pleural effusion (Pe) Pools
Pleural effusions were obtained by therapeutic thoracentesis by 
physicians at the Hospital F. J Muñiz (Buenos Aires, Argentina). 
The research was carried out in accordance with the Declaration 
of Helsinki (2013) of the World Medical Association, and was 
approved by the Ethics Committees of the Hospital F. J Muñiz 
and the Academia Nacional de Medicina de Buenos Aires (pro-
tocol number: NIN-1671-12). Written informed consent was 
obtained before sample collection. We collected a total of 43 
PE samples which were classified according to their etiology, 
being 38 of them associated to TB (TB-PE) and 5 to heart failure 
(HF-PE). Individual samples of confirmed TB patients were 
used for correlation analysis. A group of samples (n = 10) were 
pooled and used for in vitro assays to treat macrophages. The 
selection of these samples was based merely on practical reasons, 
involving those samples that have been collected earlier through 
the course of this study. The diagnosis of TB pleurisy was based 
on a positive Ziehl–Nielsen stain or Lowestein–Jensen culture 
from PE and/or histopathology of pleural biopsy, and was 
further confirmed by an Mtb-induced IFN-γ response and an 
ADA-positive test (19). Exclusion criteria included a positive 
HIV test, and the presence of concurrent infectious diseases or 
non-infectious conditions (cancer, diabetes, or steroid therapy). 
None of the patients had multidrug-resistant TB. Those PE 
samples derived from patients with pleural transudates second-
ary to heart failure (HF-PE, n = 5) were employed to prepare a 
second pool of PE, used as control of non-infectious inflamma-
tory PE. The PE were collected in heparin tubes and centrifuged 
at 300  g for 10  min at room temperature without brake. The 
cell-free supernatant was transferred into new plastic tubes, 
further centrifuged at 12,000  g for 10  min and aliquots were 
stored at −80°C. After having the diagnosis of the PE, pools 
were prepared by mixing same amounts of individual PE associ-
ated to a specific etiology. The pools were decomplemented at 
56°C for 30 min, and filtered by 0.22 µm in order to remove any 
remaining debris or residual bacteria.
FM induction
Macrophages were plated on glass coverslips within a 24-well tissue 
culture plate (Costar) at a density of 5 × 105 cells/ml per well with 
or without 20% v/v of PE, 10 µg/ml of Mtb lipids (BEI resources) 
or infected with Mtb (MOI 2:1) for 24 h. When indicated, cells 
were pre-incubated with either Cucurbitacin I (50–100  nM, 
Sigma-Aldrich), or the STAT3 inhibitor Stattic (1–20 µM, Sigma-
Aldrich), or the ACAT inhibitor Sandoz 58-035 (5–50  µg/ml, 
Sigma-Aldrich) for 2  h prior TB-PE addition and for further 
24 h during TB-PE incubation. DMSO alone was used as con-
trol. Alternatively, cells were treated with recombinant human 
IL-10 (Peprotech) at the indicated doses. Foam cell formation 
was followed by Oil Red O (ORO) staining (Sigma-Aldrich) 
as previously described (20) at 37°C for 1–5  min, and washed 
with water three times. For the visualization of the lipid bodies, 
slides were prepared using the aqueous mounting medium Poly-
Mount (Polysciences), observed via light microscope (Leica) and 
finally photographed using the Leica Application Suite software. 
Alternatively, after fixation, cells were labeled with 1  µg/ml of 
BODIPY 493/503 (Life technologies) for 15  min in order to 
visualize the lipid bodies by green fluorescence emission using a 
confocal microscope (Olympus BX51).
infection of human Macrophages  
with Mtb
Infections were performed in the biosafety level 3 laboratory at 
the Unidad Operativa Centro de Contención Biológica, ANLIS-
MALBRAN (Buenos Aires), according to the biosafety institu-
tional guidelines. Macrophages seeded on glass coverslips within 
a 24-well tissue culture plate (Costar) at a density of 5 × 105 cells/ml 
were infected with Mtb H37Rv strain at a MOI of 2:1 during 
1 h at 37°C. Then, extracellular bacteria were removed gently by 
washing with pre-warmed PBS, and cells were cultured in RPMI- 
1640 medium supplemented with 10% FBS and gentamicin 
(50 µg/ml) for 24 h. The glass coverslips were fixed with PFA 4% 
and stained with ORO, as was previously described.
Quantification of Total cholesterol
Total cholesterol was determined in TB-PE or cell lysates using the 
Colestat Enzimatico kit according to manufacturer instructions 
(Wiener Lab, Argentina). This assay is based in Trinder reaction 
in which cholesterol in the sample is quantified by enzymatic 
hydrolysis of cholesterol esters (21).
lipid analysis
Total lipids were extracted from the same number of macrophages 
with methanol/chloroform (2:1 v/v) as described by Bligh and 
Dyer (22). After extraction, lipids were dried and analyzed by 
thin layer chromatography on silica gel 60 F254 plates (Merck), 
using hexane/diethyl ether/acetic acid (75:25:1, v/v/v) as the 
developing solvent. Chemical staining with Cu-phosphoric was 
used for detection.
Phenotypic characterization  
by Flow cytometry
Macrophages were centrifuged for 7 min at 1,200 rpm and then 
stained for 40 min at 4°C with fluorophore-conjugated antibodies 
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FITC-anti-CD36 (clone 5-271), PerCP.Cy5.5-anti-CD14 (clone 
HCD14), PE-anti-CD163 (clone GHI/61), FITC-anti-CD206 
(clone C068C2) (Biolegend), FITC-anti-HLA-DR (clone G46-6), 
or PE-anti-CD274 (clone MIH1) (BD Biosciences), and in 
paral lel, with the corresponding isotype control antibody. After 
staining, the cells were washed with PBS 1×, centrifuged and 
analyzed by flow cytometry using FACSCalibur cytometer (BD 
Biosciences). The median fluorescence intensity were analyzed 
using FCS Express V3 software (De Novo Software, Los Angeles, 
CA, USA). The mean of the median fluorescence intensities 
(MFI) of the independent assays were used for comparisons 
between experimental conditions.
soluble cytokine Determinations
The amounts of human TNF-α, IL-1β, IL-10, IL-6, IFN-γ, and 
IL-4 were measured by ELISA, according to manufacturers’ 
instructions kits (TNF-α, IL-4, and IFN-γ Ready-SET-Go!™ 
Kits from eBioscience; IL-10, IL-1β, and IL-6 ELISA MAX™ 
Deluxe Kits from Biolegend). The detection limit was 3 pg/ml 
for TNF-α; 8 pg/ml for IL-10 and IL-6; 6.25 pg/ml for IFN-γ and 
IL-4; and 15.6 pg/ml for IL-1β. Murine TNF-α and IL-10 were 
measured by ELISA, according to manufacturer’s instructions 
(OptEIA™ Set kits from BD Bioscience) with a detection limit 
at 30 pg/ml.
cytokine Depletions of Pe
Tuberculosis-PE were incubated with 10 µg/ml of the following 
neutralizing antibodies for 1 h at 4°C for the specific depletion of 
IL-10 (αIL-10, clone 19F1; Biolegend), IL-6 (αIL-6, clone MQ2-
13A5; BD Bioscience), IL-1β (αIL-1β, clone 8516.311; SIGMA), 
or TNF-α (αTNF-α, clone MAb1; Biolegend). Then, 100 µl/ml of 
Protein G Sepharose beads (Amersham) were added and incu-
bated for 1 h at 4°C. Finally, TB-PE were centrifuged at 12,000 g 
to remove antibody-bead complexes and then filtered (0.22-µm 
pores) before use. IFN-γ depletion was performed by incubat-
ing TB-PE for 2 h in sterile 96-well plates that had been coated 
with the capture antibody provided by the Human IFN-γ ELISA 
Kit (BD Bioscience). In all cases, depletions were controlled 
by ELISA.
electron Microscopy
Macrophages exposed (or not) to TB-PE, and depleted (or not) 
for IL-10, were prepared for transmission electron microscopy 
study. For this purpose, cells were centrifuged at 6,000 rpm for 
1 min, fixed in 1% glutaraldehyde dissolved in 0.1 M cacodylate 
buffer (pH 7); post-fixed in 2% osmium tetroxide; dehydrated 
with increasing concentrations of ethanol and gradually infil-
trated with Epon resin (Pelco). Thin sections were contrasted 
with uranyl acetate and lead citrate (Electron Microscopy 
Sciences, Fort Washington, PA, USA) and examined with a 
FEI Tecnai transmission electron microscope (Hillsboro, OR, 
USA). For morphometry, 30  cells from each condition were 
randomly selected and digitalized at 40,000× magnification. 
Then the area of lipid electron dense vacuoles per cell were 
measured and compared in each experimental group by auto-
mated morphometry.
Proliferation of antimycobacterial  
cD4 T cells induced by Macrophages
We purified and maintained CD4 T  cells from blood derived 
from healthy PPD+ donors as previously demonstrated (23). 
In parallel, we cultured autologous monocytes to generate mac-
rophages and exposed them or not to TB-PE 20% v/v for 24 h. 
The next day, the medium was replaced, and macrophages were 
loaded with mycobacterial antigens by adding γ-irradiated Mtb 
at 2 bacteria to 1 macrophage ratio for further 24 h. Thereafter, 
the medium was replaced and autologous carboxyfluorescein 
succinimidyl ester (CFSE)-labeled CD4 T cells (Invitrogen) were 
added at a ratio of 10 lymphocytes to 1 macrophage for 5 days, 
as detailed previously (24). To determine IFN-γ production 
among proliferating CD4 T cells (CFSElow), brefeldin A (5 µg/ml; 
Sigma Chemical Co.) was added 4  h prior the end of the 
coculture to block cytokine secretion. Thereafter, CFSE-labeled 
lymphocytes were first stained with anti-CD4-PerCP-Cy5.5 
mAbs (eBioscience), then fixed with 0.5% PFA for 15  min. 
Second, cells were permeabilized with 500  µl Perm2 (Becton 
Dickinson, Cockysville, MD, USA) for 10  min and incubated 
with anti-IFN-γ-PE mAb (Invitrogen, CA, USA). Cells were 
gated according to its FSC and side scatter (SSC) properties ana-
lyzed on FACScan (Becton Dickinson). In order to gate out dead 
lymphocytes, the gate of CD4 T cells with increased SSC and low 
FSC was excluded (25). Isotype matched controls were used to 
determine auto-fluorescence and non-specific staining. Analysis 
was performed using the FCS Express (De Novo Software) and 
results were expressed as percentages of IFN-γpos/CFSElow/
CD4pos T cells induced by the different macrophage populations. 
To complement these results, the amounts of IFN-γ released 
in the supernatant throughout the coculture were determined 
by ELISA according to the manufacturer’s kit indications (BD 
Bioscience).
Measurement of Bacterial intracellular 
growth in Macrophages by colony 
Forming Unit (cFU) assay
Macrophages exposed (or not) to TB-PE, were infected with 
H37Rv Mtb strain at a MOI of 1  bacteria/cell in triplicates. 
After 2 h, extracellular bacteria were removed by gently washing 
four times with pre-warmed PBS. At 4 h and days 3, 6, and 10, 
cells were lysed in 0.1% SDS and neutralized with 20% Bovine 
Serum Albumine in Middlebrook 7H9 broth. Serial dilutions of 
the lysates were plated in triplicate, onto 7H11-Oleic Albumin 
Dextrose Catalase (OADC, Difco) agar medium for CFU scoring 
at 21 days later.
Western Blots
Macrophages were treated (or not) with TB-PE. Following the 
different experimental treatments, cells were lysed in ice-cold 
buffer consisting of 150 mM NaCl, 10 mM Tris, 5 mM EDTA, 
1% SDS, 1% Triton X-100, 1% sodium deoxycholate, gen-
tamicin/streptomycin, 0.2% azide plus a cocktail of protease 
inhibitors (Sigma-Aldrich). Lysates were incubated on ice for 
3  h and cleared by centrifugation for 15  min at 14,000  rpm 
at 4°C. Protein concentrations were determined using the 
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BCA protein assay (Pierce). Equal amounts of protein (40 µg) 
were then resolved on a 10% SDS-PAGE. Proteins were 
then transferred to Hybond-ECL nitrocellulose membranes 
(Amersham) for 2 h at 100 V and blocked with 1% BSA-0.05% 
Tween-20 for 1  h at room temperature. Membranes were 
then probed with primary anti-human ACAT (1:200 dilution, 
SOAT; Santa Cruz) or anti-human pY705-STAT3 (1:1,000 
dilution, Cell Signaling Technology, clone D3A7) overnight 
at 4°C. After extensive washing, blots were incubated with a 
HRP-conjugated goat anti-rabbit IgG Ab (1:5,000 dilution; 
Santa Cruz Biotechnology) or HRP-conjugated goat anti-
mouse IgG Ab (1:2,000 dilution; Santa Cruz Biotechnology) 
for 1 h at room temperature. Immunoreactivity was detected 
using ECL Western Blotting Substrate (Pierce). Protein 
bands were visualized using Kodak Medical X-Ray General 
Purpose Film. For internal loading controls, membranes were 
stripped by incubating in buffer consisting of 1.5% Glycine, 
0.1% SDS, 1% Tween-20, pH 2.2 for 10 min twice, extensively 
washed and then reprobed with anti-β-actin (1:2,000 dilution; 
ThermoFisher, clone AC-15) or anti-STAT3 Ab (1:1,000 dilu-
tion; Cell Signaling Technology, clone D1A5). Results from 
Western blot were analyzed by densitometric analysis (Image 
J software).
immunostaining
Macrophages were plated on glass coverslips and were treated 
with or without 20% v/v of TB-PE for 24  h. Cells were fixed 
with PFA 4% for 20 min at room temperature and then PFA was 
quenched with 50 mM NH4Cl for 2 min. Cells were rinsed in PBS 
once and then were labeled with 1  µg/ml of BODIPY 493/503 
(Life technologies) for 15 min before permeabilization with PBS-
Triton X-100 0.1% for 10 min. Cells were then incubated with 
PBS-BSA 3% w/v for 30 min prior to overnight incubation at 4°C 
with primary anti-human pY705-STAT3 (dilution 1/100, Cell 
Signaling Technology, Clone D3A7). Cells were then washed and 
incubated with Goat anti-Mouse IgG, AlexaFluor 555 (dilution 
1/1,000, Cell Signaling Technology) for 1 h at room temperature. 
Cells were extensively washed and then incubated for 10 min with 
DAPI in PBS-BSA 1% (500 ng/ml, Sigma-Aldrich). Finally, slides 
were mounted and visualized with a Leica DM-RB fluorescence 
microscope.
Mice
Wild-type (WT) BALB/c and IL-10 knockout (IL-10 KO) 
(C.129P2(B6)-IL-10 tm1Cgn/J) BALB/c male mice (8–12 weeks 
old), were obtained from the Leloir Institute Foundation. Ani-
mals were bred and housed in accordance with the guidelines 
established by the Institutional Animal Care and Use Committee 
of Institute of Experimental Medicine (IMEX)-CONICET-
ANM. All animal procedures were shaped to the principles 
set forth in the Guide for the Care and Use of Laboratory 
Animals (26).
generation of BMDMs
Femurs and tibia from WT and IL-10 KO mice were removed after 
euthanasia and the bones were flushed with RPMI-1640 medium 
by using syringes and 25-Gauge needles. The cellular suspension 
was centrifuged and the red blood cells were removed. The 
BMDMs were obtained by culturing the cells with RPMI-1640 
medium containing l-glutamine, pyruvate, β-mercaptoethanol 
(all from Sigma-Aldrich), 10% FCS and 20  ng/ml of murine 
recombinant M-CSF (Biolegend) at 37°C in a humidified incu-
bator for 7–8  days. Differentiated BMDMs were re-plated into 
24-well tissue culture plates in complete medium prior to cell 
stimulation with Mtb lipids for 24 h. Alternatively, recombinant 
murine IL-10 (Peprotech) at 10 ng/ml was added to the cultures 
for 24 h.
statistical analysis
All values are presented as mean and SEM of a number of inde-
pendent experiments. Independent experiments are defined as 
those performed with macrophages derived from monocytes 
isolated independently from different donors. As most of our 
datasets did not pass the normality tests, non-parametric tests 
were applied. Comparisons between more than two paired data 
sets were made using the Friedman test followed by Dunn’s 
Multiple Comparison Test. Comparisons between two paired 
experimental conditions were made using the two-tailed 
Wilcoxon Signed Rank. Correlation analyses were determined 
using the Spearman’s rank test. For all statistical comparisons, 
a p value < 0.05 was considered significant.
resUlTs
Tuberculous Pe Fluids induce lipid  
Bodies accumulation in Macrophages
It has been demonstrated that Mtb induces a lipid-rich foam cell 
phenotype in host macrophages (6–8, 27), possibly via TLR2 
and TLR6 activation (28). Moreover, merely isolated lipids from 
Mtb were able to induce the foamy phenotype (7, 27). Based on 
this knowledge, we aimed to determine whether soluble factors 
found in physiological samples derived from active TB patients 
could promote the generation of FM. To this end, we treated 
human M-CSF-driven macrophages with cell-free prepara-
tions of PE derived from patients with tuberculosis (TB-PE) in 
order to mimic a genuine microenvironment derived during 
Mtb infection. According to the pattern of staining of neutral 
lipids with ORO, we observed that TB-PE treatment induced 
lipid bodies accumulation in macrophages to the same extent as 
Mtb infection or exposure to Mtb-derived lipids (Figure 1A). 
We also demonstrated that the formation of lipid bodies was 
specific for TB-PE treatment in comparison to PE from patients 
with heart failure (HF-PE) (Figure 1B). Moreover, biochemical 
analysis of the lipids recovered from macrophages identified 
higher abundance of cholesteryl esters and triacylglycerols 
in TB-PE-treated macrophages in comparison to control or 
HF-PE-treated macrophages (Figure 1C). Additionally, unlike 
HF-PE, the treatment with TB-PE resulted in an increase of the 
total intracellular cholesterol content (Figure 1D) and a twofold 
increase of CD36 expression (Figure 1E). Therefore, soluble fac-
tors released during pleural Mtb infection induced lipid body 
accumulation in human macrophages that typically confirm the 
FM phenotype.
FigUre 1 | Continued
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FigUre 1 | Tuberculous pleural effusions (TB-PE) induce lipid bodies accumulation in macrophages. (a) Human monocyte-derived macrophages (MDM)  
were treated either with TB-PE or with Mycobacterium tuberculosis (Mtb) lipids, or infected with Mtb H37Rv for 24 h and then stained with Oil Red O (ORO). 
Representative images are shown in left panels (40× magnification) and the integrated density of ORO staining is shown in right panels. Values are expressed as 
means ± SEM of six independent experiments, considering five microphotographs per experiment. Wilcoxon signed rank test: *p < 0.05. (B) MDM were treated 
with TB-PE or PE from heart failure patients (HF-PE) and stained with ORO (n = 5). (c) Left panel shows a representative thin layer chromatographic analysis of 
lipids from MDM treated or not with either TB-PE or HF-PE. Total lipids were extracted from untreated MDM (lane 1), TB-PE-treated MDM (lane 2), HF-PE-treated 
MDM (lane 3), and the standard lipids triacylglycerol (TAG, lane 4) and free cholesterol (CHO, lane 5). Cholesterol esters (CE) are also indicated. Right panels depict 
the area of spots for CE, TAG, and CHO in control and TB-PE or HF-PE treated MDM (n = 4). (D) Intracellular total cholesterol (CHO) content in MDM exposed or 
not to TB-PE or HF-PE measured by an enzymatic method (n = 5). (e) Mean fluorescence intensity (MFI) of CD36 cell-surface expression in MDM exposed or not  
to TB-PE or HF-PE measured by flow cytometry (n = 5). (B–e) Friedman test followed by Dunn’s Multiple Comparison Test: *p < 0.05; **p < 0.01 for TB-PE vs Ctl  
or as depicted by lines.
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FM induced by Tuberculous Pe Display 
immunosuppressive Properties
In order to assess whether the differentiation into FM induced 
by TB-PE may have a negative impact on the development of 
the antimycobacterial response, we determined phenotype and 
functions of TB-PE-induced FM. As observed in Figure  2A, 
macrophages treated with TB-PE displayed a higher expression 
of anti-inflammatory markers such as CD163, mannose receptor 
or CD206 (MRC1), and PD-L1, and a lower expression of the 
MHC class II cell-surface receptor, HLA-DR. In accordance 
with the acquisition of this anti-inflammatory profile, TB-PE-
induced FM secreted higher levels of IL-10 and lower levels 
of TNF-α upon stimulation with irradiated Mycobacterium 
tuberculosis (iMtb) than untreated cells (Figure  2B). In order 
to assess the effect of TB-PE treatment on the presentation of 
mycobacterial antigens, macrophages were treated with or 
without TB-PE for 24 h, washed and stimulated with iMtb for 
further 24 h. Thereafter, cells were washed and cocultured with 
autologous CFSE-labeled CD4 T  cells derived from healthy 
PPD positive subjects for 5 days. Based on the CFSE labeling of 
CD4 T cells, while TB-PE-treated macrophages did not induce 
differential levels of proliferation of antimycobacterial CD4 
T cells (Figure 2C), they promoted differential distribution of 
the IFN-γ producing clones (Figure  2D). In particular, those 
macrophages treated with TB-PE induced lower percentages 
of IFN-γ producing clones (Figure 2D) and a lower release of 
IFN-γ (Figure 2E), as compared to untreated macrophages in 
response to iMtb stimulation. Of note, IL-4 and IL-17 contents 
were undetectable in these assays (data not shown). Therefore, 
the activation of Ag-specific IFN-γ-producing CD4 T cells was 
impaired when macrophages were exposed to TB-PE, suggest-
ing that the accumulation of lipid bodies is accompanied by a 
reduced capacity to activate antimycobacterial Th1 cells.
Next, we assessed whether the treatment with TB-PE had an 
impact on the control of the bacillary load. To accomplish this, 
macrophages were treated with TB-PE for 24  h, washed and 
infected with Mtb. Although no differences were observed in 
the uptake of the mycobacteria as judged by the scoring of the 
CFU at 4 h post-infection (Figure 2F), a significant increase in 
the bacillary load was observed in TB-PE-treated macrophages at 
later time points (Figure 2G). Therefore, FM induced by TB-PE 
are more susceptible to Mtb intracellular growth.
il-10 Promotes accumulation of lipid 
Bodies in Macrophages under TB-Pe 
Treatment
In order to evaluate the host factors involved in promoting the 
accumulation of lipid bodies by TB-PE, we depleted diffe rent 
cytokines known to be highly present in this fluids (29, 30), 
including IL-10, TNF-α, IL-1β, IL-6, and IFN-γ. We then 
evaluated the ability of these depleted-PE to induce the foamy 
phenotype in macrophages. The depletion of each individual 
cytokine was confirmed by ELISA (Figure S1A in Supplementary 
Material). Interestingly, only the depletion of IL-10 from TB-PE 
was capable of preventing lipid bodies accumulation (Figure 3A). 
This result was also confirmed by labeling the cells with Bodipy 
staining (Figure S1B in Supplementary Material). In addition, 
macrophages exposed to IL-10-depleted TB-PE showed a reduc-
tion of intracellular cholesterol content and CD36 cell-surface 
expression in comparison to those cells treated with non-depleted 
or depleted of any other cytokines (Figures 3B,C). In line with 
these results, the addition of recombinant IL-10 to the IL-10-
depleted TB-PE restored the acquisition of the foamy phenotype 
in a dose-dependent manner (Figure 3D). Of note, the addition 
of IL-10 in the absence of TB-PE did not induce the foamy 
phenotype (Figure 3D). Thereafter, we determined the presence 
of the lipidic vacuoles by electron microscopy in macrophages 
treated with TB-PE depleted (or not) of IL-10. As it is shown 
in Figure 3E, while untreated macrophages showed numerous 
pseudopodia and empty cytoplasmic vacuoles, TB-PE-treated 
macrophages displayed electron dense lipid osmiophilic vacuoles, 
FigUre 2 | Continued
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which correspond to lipid bodies. Interestingly, macrophages 
treated with IL-10-depleted TB-PE showed smaller-sized lipidic 
vacuoles than those exposed to non-depleted TB-PE. These 
results indicate that the IL-10 present in TB-PE is a key host 
factor promoting the lipid-laden phenotype in the presence of 
exogenous lipids.
il-10 levels correlate with FM  
abundance in Pe
In order to evaluate whether IL-10 level is associated to the 
acquisition of the foamy phenotype in the course of a Mtb natural 
infection, we assessed the levels of IL-10 and total cholesterol in 
individual preparations of TB-PE, and the numbers of FM found 
FigUre 3 | Interleukin-10 (IL-10) promotes lipid bodies accumulation in macrophages treated with tuberculous pleural effusion (TB-PE). (a–c) Human monocyte-
derived macrophages (MDM) were treated with TB-PE depleted or not for different cytokines for 24 h and (a) lipid bodies’ content was measured by Oil Red O 
(ORO) staining (n = 4). (B) Intracellular cholesterol (CHO) content measured by an enzymatic method (n = 4) was determined. (c) Mean fluorescence intensity (MFI) 
of CD36 cell-surface expression was measured by flow cytometry (n = 4). (D) MDM were treated (or not) with TB-PE depleted or not of IL-10 in the presence of 
different amounts of recombinant human IL-10 (rIL-10) for 24 h and lipid bodies content was measured by ORO staining (n = 6). (e) Representative electron 
microscopy micrographs of MDM treated with TB-PE depleted or not of IL-10. White asterisks indicate large electron dense osmiophilic vacuoles and arrows point 
small sized ones. Morphometric study of the area per vacuole in each condition is shown (n = 14). (a–e) Friedman test followed by Dunn’s Multiple Comparison 
Test: *p < 0.05; **p < 0.01; ***p < 0.001 for experimental condition vs Ctl or as depicted by lines.
FigUre 2 | Macrophages treated with tuberculous pleural effusion (TB-PE) display immunosuppressive properties. (a) Mean fluorescence intensity (MFI)  
of CD163, PDL-1, MR, and HLA-DR measured by flow cytometry in human monocyte-derived macrophages (MDM) exposed or not to TB-PE (n = 5). Wilcoxon 
signed rank test: *p < 0.05. (B) Levels of secreted IL-10 and TNF-α by MDM exposed or not to TB-PE in response to irradiated Mycobacterium tuberculosis (iMtb) 
measured by ELISA (n = 5). Friedman test followed by Dunn’s Multiple Comparison Test: *p < 0.05; **p < 0.01, for iMtb-stimulated vs unstimulated, or as indicated 
in the graph. (c–e) MDM from healthy PPD+ donors exposed or not to TB-PE for 24 h, were stimulated or not with iMtb for 24 h and then used as antigen 
presenting cells (APC) in autologous proliferation assays. Cocultures were performed with autologous carboxyfluorescein succinimidyl ester (CFSE)-labeled CD4 
T cells at a ratio of 10 T cells: 1MDM. (c) Representative histograms showing CFSE labeling in CD4pos T cells activated by macrophages exposed (or not) to TB-PE, 
loaded (or not) with iMtb. Right panel shows the quantification of the percentages of proliferating CD4pos T cells (CFSElow/CD4pos cells) in each condition. Loaded vs 
unloaded with iMtb: *p ≤ 0.05 (n = 4). (D) Representative dot plots showing CD4 and IFN-γ expression among CFSElow/CD4pos T cells activated by MDM exposed 
(or not) to TB-PE, loaded (or not) with iMtb. Right panel shows the quantification of the percentages of proliferating IFN-γ-producing CD4pos T cells (IFN-γpos/CFSElow/
CD4pos T cells) in each condition (n = 4). Friedman test followed by Dunn’s Multiple Comparison Test: *p < 0.05, for iMtb-stimulated vs unstimulated, or as indicated 
in the graph. (e) The amounts of IFN-γ released throughout the coculture were determined by ELISA. Friedman test followed by Dunn’s Multiple Comparison Test: 
*p < 0.05; **p < 0.01, for iMtb-stimulated vs unstimulated, or as indicated in the graph. (F) Bacillary loads in MDM treated (or not) with TB-PE, washed, and infected 
with Mycobacterium tuberculosis (Mtb) strain H37Rv for 4 h (n = 6). Wilcoxon signed rank test. (g) Intracellular colony forming units were determined at different 
time points in MDM treated with TB-PE for 24 h, washed and infected with Mtb (n = 10). Wilcoxon signed rank test: *p < 0.05; **p < 0.01; ***p < 0.001 for TB-PE 
treated vs Ctl.
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within the pleural fluids mononuclear cells (PFMC). We found 
that levels of IL-10 and total cholesterol were positively correlated 
(Figure 4A), unlike other cytokines such as IFN-γ, IL-6, TNF-α, 
and IL-1β (Figure S2 in Supplementary Material). Noticeably, 
there was also a positive correlation between the level of IL-10 
and the number of FM among the PFMC (Figure 4B). Moreover, 
lipid-laden CD14+ cells were found in the pleural compartment 
but not in paired peripheral blood (Figure  4C). These results 
FigUre 4 | Cholesterol levels and foamy macrophages (FM) are associated with interleukin-10 (IL-10) amounts present in tuberculous pleural effusion (TB-PE). 
(a,B) Correlation analysis between the levels of IL-10 and (a) the cholesterol content (n = 38) or (B) the number of lipid-laden CD14+ cells within the pleural fluids 
mononuclear cells (PFMC) (n = 12) found in individual preparations of TB-PE. In B log-10 scale for both axes is used. Linear regression lines are shown. Spearman’s 
rank test. (c) Representative image of ORO staining of CD14+ cells isolated from paired peripheral blood mononuclear cells (PBMC) and PFMC is shown (40× 
magnification).
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support the idea that IL-10 potentiates the acquisition of the 
foamy program in human macrophages in the context of a natural 
infection.
il-10 Deficiency Prevents the Foamy 
Phenotype in BMDM
To confirm the role of IL-10 in the differentiation of FM, we evalu-
ated whether BMDM derived from IL-10-knock out (KO) mice 
could indeed become FM after the treatment with lipids from 
Mtb. First, we determined IL-10 production in M-CSF-derived 
BMDM from WT mice stimulated with mycobacterial lipids for 
24  h. As shown in Figure  5A, unlike the undetectable level of 
TNF-α (data not shown), BMDM secreted IL-10 in response to 
mycobacterial lipid-stimulation. Second, we compared whether 
BMDM derived from WT or IL-10-KO mice differed in their 
propensity to accumulate lipid bodies in response to Mtb-derived 
lipids. As illustrated in Figures 5B,C, IL-10-deficiency prevented 
the foamy phenotype induced by Mtb lipids, which in turn 
could be partially reverted by the addition of exogenous IL-10. 
In agreement with our previous results, exogenous IL-10 did 
not induce the foamy phenotype in the absence of the source of 
lipids in BMDM. These results obtained in murine macrophages 
confirm those obtained in human TB-PE-treated macrophages, 
demonstrating the key role of IL-10 in favor of the differentiation 
program toward foamy cells.
The il-10/sTaT3 axis is involved in the  
FM Differentiation induced by TB-Pe
Considering the role of IL-10 in promoting the differentiation 
of macrophages into FM, and that STAT3 is a pivotal tran-
scriptional factor induced by IL-10 (31, 32), we studied the 
contribution of STAT3 activation in the induction of the foamy 
phenotype by measuring its phosphorylated form (pSTAT3). 
First, we determined that STAT3 was activated in TB-PE-treated 
macrophages detecting its phosphorylated form by western 
blot and immunofluorescence microscopy (Figures  6A,B). 
As depicted in Figure  6B FM induced by TB-PE showed 
nuclear localization of STAT3 phosphorylated on tyrosine 
705, reflecting STAT3 activation. Importantly, pharmaco-
logical inhibition of STAT3 with Stattic (or with cucurbitacin 
I) prevented the accumulation of lipid bodies in macrophages 
in a dose-dependent manner (Figure  6C; Figures S3A,B in 
Supplementary Material). Therefore, the enhancement of FM 
differentiation driven by IL-10 is mediated by STAT3.
il-10 enhances acaT expression  
in TB-Pe-Treated Macrophages  
leading to FM Differentiation
In order to elucidate the mechanism by which IL-10 promotes 
FM differentiation, we assessed the expression of ACAT, which is 
central for the biogenesis of lipid bodies by converting free- into 
FigUre 5 | Interleukin-10 (IL-10) deficiency reduces lipid bodies accumulation in bone marrow-derived mouse macrophages (BMDM) in response to 
Mycobacterium tuberculosis (Mtb) lipids. (a) BMDM from wt mice were treated or not with Mtb lipids for 24 h and the levels of secreted IL-10 were measured by 
ELISA (n = 5) Wilcoxon signed rank test: *p < 0.05. (B,c) BMDM from wt or IL-10−/− mice were treated or not with Mtb lipids in the presence or not of recombinant 
murine IL-10 for 24 h and then stained with Oil Red O (ORO). The integrated density of ORO staining (B) and representative images (c) are shown (n = 6). Friedman 
test followed by Dunn’s Multiple Comparison Test: *p < 0.05; **p < 0.01; ***p < 0.001 as depicted by lines.
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esterified-cholesterol that are eventually packed inside the lipid 
droplets (33). We first showed that the foamy phenotype induced 
by TB-PE was dependent on ACAT activity, as judged both by the 
increase of ACAT expression after TB-PE treatment (Figure 7A), 
and by the blocking of the accumulation of lipid bodies in the 
presence of Sandoz, a specific inhibitor of ACAT (Figure  7B). 
Noticeably, the inhibition of ACAT lead to reduced amounts 
of both cholesteryl esters and triacylglycerols in TB-PE-treated 
macrophages (Figure 7C), confirming the involvement of ACAT 
in FM formation upon TB-PE treatment. We then assessed ACAT 
expression in IL-10-depleted TB-PE and we found that its expres-
sion was reduced in the absence of IL-10 (Figure 7A). In agree-
ment with this result, ACAT induction by TB-PE was abolished 
when STAT3 activity was inhibited (Figure 7D). Therefore, the 
IL-10/STAT3 axis activated by TB-PE enhances FM differentia-
tion through the upregulation of ACAT expression, leading to an 
increased biogenesis and accumulation of lipid bodies.
Based on our findings, we propose a model for the modula-
tion of FM in the context of a physiologically relevant microen-
vironment promoted by Mtb infection for which the axis IL-10/
STAT3 induces the accumulation of lipid bodies via ACAT 
upregulation. This in turn is accompanied by an increase of 
CD36 and the acquisition of immunosuppressive properties, 
such as a reduced induction of antimycobacterial Th1 clones, an 
enhanced production of IL-10 and a more permissive phenotype 
for bacillary growth (Figure 8).
DiscUssiOn
Tuberculosis, as a chronic condition, entails the establishment 
of extensive metabolic remodeling in both host and pathogen. 
One of the consequences of this adaptation is the formation of 
FM. Since FM have been associated with the bacilli persistence 
and tissue pathology (6, 8, 12, 27, 34), we aimed to determine 
which host factors may contribute to enlarge the pool of FM 
in TB. In this sense, we used the acellular fraction of TB-PE 
to mimic those soluble factors released locally during Mtb 
infection. Although pleural disease due to Mtb is generally 
categorized as extra-pulmonary, there is an intimate anatomic 
relationship between the pleura and the pulmonary parenchyma 
(35, 36). Current literature supports the notion that TB-PE is 
the consequence of a direct local infection with a cascade of 
events, including an immunological response, instead of the 
result of a pure delayed hypersensitivity reaction, as previously 
thought (37). Even though we cannot state that macrophages 
infiltrating the pleural cavity will reproduce with fidelity those 
macrophages in the infected alveolar space or lung interstitial 
tissue, we can affirm that TB-PE represents microenvironment 
from a human respiratory cavity that is impacted by the infec-
tion. To our knowledge, this is the first time that such a complex 
but physiologically relevant human sample has been used in 
order to study the biology of FM. Using this in vitro model, we 
demonstrated that the acellular fraction of TB-PE induces the 
accumulation of lipid bodies in human macrophages. Moreover, 
our finding was validated by the detection of lipid-laden CD14+ 
cells isolated directly from the mononuclear cells of the PE, pro-
viding physiological relevance to our in vitro model. Taking into 
account that tuberculous PE has, if any, very few bacilli content 
(38), and that it displays high cholesterol content, we infer that 
in our model the source of lipids feeding the lipid bodies in the 
macrophages are likely host-derived components instead of 
mycobacterial ones.
FigUre 6 | Signal transducer and activator of transcription 3 (STAT3) activation enhances lipid bodies accumulation induced by treatment of macrophages with 
tuberculous pleural effusion (TB-PE). (a) Analysis of p705-STAT3, STAT3, and β-actin protein expression level by western Blot (left panel) and quantification (right 
panel; n = 4) in human monocyte-derived macrophages (MDM) treated with TB-PE for 24 h. Wilcoxon signed rank test: *p < 0.05 (B) MDM were treated or not with 
TB-PE for 24 h and then were fixed, labeled with Bodipy 493/503 (green), permeabilized, and stained for p705-STAT3 (Red) and DAPI (blue). Representative images 
are shown. Scale bar, 10 µm. (c) MDM were treated or not with different concentrations of Stattic (STAT3 inhibitor, ST) for 2 h and then exposed or not to TB-PE for 
24 h. Lipid bodies’ content was determined by Oil red O (ORO) staining (n = 6). Representative images are shown and the integrated density of ORO staining is 
shown. Friedman test followed by Dunn’s Multiple Comparison Test: *p < 0.05; **p < 0.01 for TB-PE treated vs Ctl, or as depicted by lines.
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Although lipid bodies were qualified as passive organelles 
involved in lipid storage, it became clear that these organelles 
play a central role in several inflammatory (e.g., atherosclerosis) 
or chronic infectious diseases (e.g., TB) (8, 13). In this work, we 
provide evidence that FM differentiation induced by TB-PE is 
potentiated by IL-10 in association with the acquisition immu-
nosuppressive properties, impairing the activation of antimyco-
bacterial Th1 clones, producing the anti-inflammatory cytokine 
IL-10 and bearing higher bacillary loads. This is in line with 
previous reports characterizing the immunosuppressive profile 
in macrophages activated by the IL-10/STAT3 signaling pathway 
(39, 40). In this study, we show that FM formation depends 
(albeit partially) on the IL-10/STAT3 axis, and thus establish-
ing an association between both processes (accumulation of 
lipid bodies and immunosuppression). Within this context, we 
observed that both processes are enhanced by the IL-10/STAT3 
signaling pathway, arguing for likelihood of two independent 
outcomes emanating from the same signaling axis (Figure  8). 
Of note, it has been reported that the synthetic glucocorticoid 
dexamethasone can upregulate ACAT expression promoting 
formation of FM (41). Although there are extensive reports 
demonstrating transcriptional interactions between STAT3 and 
glucocorticoids leading to repression or synergism of target genes 
(42), it is interesting to notice that both IL-10 and glucocorticoids 
can polarize macrophages into an immunoregulatory profile (43). 
Based on that, we propose that the establishment of a foamy phe-
notype is accompanied by the acquisition of immunosuppressive 
properties.
It should be mentioned that Stattic is not an inhibitor com-
pletely specific for STAT3 (44). In this regard, a desirable goal 
is the discrimination between STAT3 and STAT1 involvement 
because both transcription factors can be activated by IL-10 
(albeit at different levels), and because of their high degree 
of homology, particularly in their SH2 domains (44). Under 
our experimental conditions, unlike the strong activation of 
STAT3, we did not observe the phosphorylation of STAT1 
FigUre 7 | The interleukin-10 (IL-10)/signal transducer and activator of transcription 3 (STAT3) axis promotes foamy macrophage formation through ACAT 
upregulation. (a) Analysis of ACAT and β-actin protein expression level by western Blot (left panel) and quantification (right panel; n = 5) in human monocyte-derived 
macrophages (MDM) treated with tuberculous pleural effusion (TB-PE) for 24 h depleted or not for IL-10. (B) MDM were treated or not with different concentrations 
of Sandoz (Sz, ACAT inhibitor) for 1 h, exposed or not to TB-PE for 24 h, and then stained with Oil Red O (ORO). The Integrated density and representative images 
are shown (n = 6). (a,B) Friedman test followed by Dunn’s Multiple Comparison Test: *p < 0.05; **p < 0.01 for TB-PE treated vs Ctl, or as depicted by lines. (c) Thin 
layer chromatographic analysis of lipids from MDM treated or not with TB-PE in the presence or not of Sz. Total lipids were extracted from untreated MDM (lane 1), 
TB-PE-treated MDM (lane 2), TB-PE-treated MDM in the presence of Sz (lane 3), and the standard lipids triacylglycerol (TAG, lane 4) and cholesterol (CHO, lane 5). 
Cholesterol esters (CE) are also indicated. Right panels depict the area of spots for CE, TAG, and CHO in control and TB-PE in the presence or not of Sz treated 
MDM (n = 2). (D) Analysis of ACAT and β-actin protein expression level by Western Blot (left panel) and quantification (right panel; n = 3) in MDM treated or not with 
different concentrations of Stattic (ST) for 2 h and then exposed or not to TB-PE for 24 h. Friedman test followed by Dunn’s Multiple Comparison Test: *p < 0.05 for 
TB-PE treated vs Ctl.
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in macrophages treated with TB-PE (data not shown and 
Figure 6). Likewise, the depletion of IFN-γ (a STAT1 activat-
ing cytokine) from TB-PE did not prevent the accumulation 
lipid bodies in macrophages (Figures  3A–C). Therefore, we 
consider that our experimental model is dependent of STAT3 
instead of STAT1.
FigUre 8 | Interleukin-10 (IL-10) promotes foamy macrophage (FM) formation in an IL-10/signal transducer and activator of transcription 3 (STAT3)-dependent 
manner in tuberculosis (TB). According to our results, FM induced by pleural effusion from TB patients display immunosuppressive properties such as high IL-10 
release, low TNF-α production, impaired Th1 activation, and high bacillary loads. At the same time, lipid bodies’ accumulation is enhanced by IL-10/STAT3 axis 
through an increase of CD36 cell-surface expression levels and ACAT expression. It has been demonstrated that Mycobacterium tuberculosis (Mtb)-containing 
phagosomes migrate toward these lipid bodies and engulf them (7). This mechanism ensures protection from microbicidal pathways and allows persistence of the 
bacilli inside host. Our results provide additional mechanisms by which the environment created by the infection context drives the FM differentiation even in the 
absence of the pathogen.
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Our findings are in agreement with previous reports that 
demonstrated that macrophages exposed to lipids displayed 
impaired immune functions. Particularly, FM generated in vitro 
by the incubation with acetylated LDL displayed a reduced 
expression of pro-inflammatory genes (45). In addition, the liga-
tion of the pregnane X receptor in human macrophages, which 
was associated to foamy formation, resulted in the impairment 
of the secretion of pro-inflammatory cytokines, phagolysosomal 
fusion and apoptosis (46). Moreover, a recent study showed that 
the treatment of human macrophages with surfactant lipids 
resulted in the reduction of TNF-α release and the enhance-
ment of Mtb growth (14). Likewise, cholesterol-exposed THP1 
macrophages failed both to produce TNF-α in response to Mtb 
and to clear the infection (15). To the best of our knowledge, 
we provide the first evidence that FM display a reduced ability 
to activate a recall Th1 response of specific antimycobacterial 
T cell clones. Therefore, we propose that FM significantly subvert 
the host immune response by impairing both the innate and 
the adaptive immune branches, and we predict a close relation-
ship between lipid exposure, foamy phenotype acquisition and 
immu nosuppressive properties.
Our study also provides additional mechanisms by which 
the environment created during infection can drive the foamy 
differentiation even in the absence of a direct contact with 
the pathogen. On the one hand, Mtb-infected macrophages 
can acquire a foamy phenotype as demonstrated in this study 
and several others (6–9, 27). Indeed, the accumulation of lipid 
bodies within infected cells has undesirable effects for the host, 
such as the protection of the pathogen against microbicidal 
mechanisms (10) and the acquisition of a dormancy phenotype, 
which confers tolerance to several front-line antibiotics (9). 
On the other hand, uninfected macrophages can also be dri ven 
into foamy cells by IL-10 and a source of lipids. These uni-
nfected lipid-rich cells abrogate the host innate and adaptive 
cellular defense mechanisms, and when infected, they become a 
niche favoring pathogen persistence. In the latter case, we infer 
that uninfected individuals suffering from a lipid dysbalance 
may bear an enlarged pool of lipid-rich cells that potentially 
increase the susceptibility, persistence and/or progression of TB. 
In fact, diabetes and obesity have been associated with TB disease 
progression (47, 48), and even asymptomatic dyslipidemia was 
correlated to a reduced antimycobacterial activity (15).
In the past, most reports focused on assessing the impact 
of certain cytokines in the accumulation of lipid bodies in 
macrophages within the context of atherosclerosis; FM were 
proposed to cause the formation of atheroma (49). In fact, IL-1β 
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and TNF-α are known to impede neutral lipid turnover in THP-1 
cells loaded with lipoproteins (50), and these pro-inflammatory 
cytokines can decrease the efflux of lipids in J774 murine mac-
rophages (51). In addition, IL-10 was shown to regulate lipid 
metabolism in human macrophages loaded with acetylated 
and oxidized LDL by increasing both cholesterol uptake and 
efflux resulting in a net increase in cholesterol content (52, 53). 
Considering that both pro- and anti-inflammatory cytokines 
were associated to the accumulation of lipid bodies, we evalu-
ated in this study the effect of depleting several cytokines from 
TB-PE on the FM formation. In our hands, unlike the depletion 
of IL-10, the foamy phenotype induced by TB-PE was not altered 
by depletion of IL-1β, TNF-α, IL-6 or IFN-γ, pointing toward a 
specific role of IL-10 in promoting FM formation in the context 
of the pleural infection. Moreover, anti-inflammatory cytokines 
such as IL-4 and IL-13 were shown to alter lipid metabolism 
in macrophages through the activation of the lipid-activated 
nuclear receptors PPARγ (54), which mediates accumulation of 
lipid bodies (55, 56). Yet, we dismiss a potential role for IL-4 in 
our model given that its level was undetectable in TB-PE samples 
(data not shown).
In summary, our present study provides insights into the 
mechanisms by which host factors can enhance FM formation 
in macrophages. This knowledge may contribute to the identi-
fication of host molecular pathways that could be modulated to 
the benefit of the patient. Besides, the complementation of the 
conventional anti-TB therapy with host-directed therapies is 
desirable in order to achieve shorter treatment times, reduction 
in lung damage caused by the disease, and lower risk of relapse 
or reinfection. In this regard, a better understanding of the 
molecular mechanisms underlying host–pathogen interactions 
could provide a rational basis for the development of effective 
anti-TB therapeutics.
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FigUre s1 | Interleukin-10 (IL-10) promotes lipid bodies’ accumulation in 
TB-PE-treated macrophages. (a) TB-PE were incubated with neutralizing 
antibodies for 1 h (4°C) for the depletion of IL-10, IL-6, IL-1β, or TNF-α, and then, 
Protein G Sepharose beads were added and incubated for 1 h (4°C). Finally, 
TB-PE was centrifuged at 12,000 × g to remove antibody-bead complexes.  
In the case of IFN-γ depletion, it was performed by incubating TB-PE for 2 h in 
sterile 96-well plates that had been coated with the capture antibody provided by 
the human IFN-γ ELISA Kit. In all cases, depletions were controlled by ELISA.  
(B) Human monocyte-derived macrophages were treated with TB-PE depleted 
or not of IL-10 for 24 h and then, cells were labeled with BODIPY 493/503 to 
visualize the lipid bodies by green fluorescence emission. The left panels are DIC 
images of the same field.
FigUre s2 | Correlation between cholesterol levels and different cytokines 
present in TB-PE. Correlation analysis between the levels of IL-6, IL-1β, TNF-α, 
or IFN-γ and the cholesterol content found in individual preparations of TB-PE  
(n = 23–24).
FigUre s3 | Signal transducer and activator of transcription 3 (STAT3) activation 
enhances lipid bodies accumulation by TB-PE. (a) Immunoblot images of 
p705-STAT3, STAT3, and β-actin (left panel); quantification of p705-STAT3 vs 
STAT3 on macrophages treated or not with Static (20 µM) or cucurbitacin (100 
nM) for 2 h and then exposed or not to TB-PE for 24 h (right panel; n = 3).  
(B) Macrophages were treated or not with different concentrations of 
cucurbitacin for 2 h and then were exposed or not to TB-PE for 24 h. Lipid 
bodies’ content was assessed by Oil Red O (ORO) staining. The results are 
shown like the integrated density of ORO staining (n = 6) (*p ≤ 0.05).
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